# 数智东南 vs 西医AI病史采集

The clearest difference is update cadence: 西医AI病史采集 at every 2 weeks against 数智东南's monthly. 西医AI病史采集 also leads on iOS requirement (11.0 vs 13.0). On price, ads, in-app purchases and device support there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

数智东南 ships an update monthly, 西医AI病史采集 every 2 weeks. The most recent releases landed on October 2, 2026 and September 27, 2026 respectively.

## The numbers

| Metric | 数智东南 | 西医AI病史采集 |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[2.0 (6 ratings)](https://appshunter.io/ios/app/id6474402905/reviews)** | — |
| Number of ratings | **6** | — |
| Positive reviews | 0.0% of reviews | — |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Monthly | **Every 2 weeks** |
| Size | 783 MB | 1.5 GB |
| Requires iOS | 13.0 | **11.0** |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 4+ | 17+ |
| Developer | [Southeast University](https://appshunter.io/developer/1530157421) | [南京宁域智能科技有限公司](https://appshunter.io/developer/1788252993) |

## What reviewers say

### 数智东南

[App page](https://appshunter.io/ios/app/id6474402905)

**Features:** macOS Compatibility, Apple Wallet

**In-app purchases:** none


### 西医AI病史采集

[App page](https://appshunter.io/ios/app/ai/id6752018124)

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is 数智东南 free?

数智东南 is free to download, with no in-app purchases.

### Is 西医AI病史采集 free?

西医AI病史采集 is free to download, with no in-app purchases.

### Do 数智东南 or 西医AI病史采集 have ads?

Neither 数智东南 nor 西医AI病史采集 shows ads.

### Which is updated more often, 数智东南 or 西医AI病史采集?

数智东南 ships an update monthly, and 西医AI病史采集 every 2 weeks. Most recently, 数智东南 was updated on October 2, 2026 and 西医AI病史采集 on September 27, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*